FDA approves Sarclisa® (isatuximab-irfc) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myelomaPRNewsWire • 03/31/21
Sanofi: Information concerning the total number of voting rights and shares - February 2021GlobeNewsWire • 03/31/21
Regeneron/Sanofi Boast Positive Overall Survival Results In Late-Stage Cervical Cancer StudyBenzinga • 03/15/21
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidateGlobeNewsWire • 03/12/21
Sanofi (SNY) Presents at Barclays Global Healthcare Conference 2021 (Transcript)Seeking Alpha • 03/10/21
Will Sanofi and GlaxoSmithKline Be Too Late to the Party With Their COVID Vaccine?The Motley Fool • 03/05/21
Sanofi/Regneron's Dupixent Application For Asthma In Children Accepted For FDA ReviewBenzinga • 03/04/21
Sanofi's Board of Directors proposes the appointment of Christian Brandts and Barbara Lavernos as Board MembersGlobeNewsWire • 03/03/21
Sanofi (SNY) Presents at Cowen 41st Annual Healthcare Conference (Transcript)Seeking Alpha • 03/02/21
XNK Therapeutics partners with Karolinska Institutet on Phase II study in patients with multiple myeloma with support from SanofiPRNewsWire • 02/26/21